ClinicalTrials.Veeva

Menu

Ventricular Tachycardia Cohort

Capital Medical University logo

Capital Medical University

Status

Not yet enrolling

Conditions

Ventricular Tachycardia (VT)

Treatments

Device: Intervention

Study type

Observational

Funder types

Other

Identifiers

NCT07149701
KS2025135

Details and patient eligibility

About

The goal of this observational study is to detect the long-term risk of a composite endpoint event in adult patients with ventricular tachycardia (VT) who are managed with catheter ablation or non-ablation management (including modern drug therapy and/or ICD therapy).

Enrollment

1,500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Sustained ventricular tachycardia (VT), defined as VT lasting ≥30 seconds or requiring intervention due to hemodynamic compromise within 30 seconds; or Clinically significant non-sustained VT (NSVT) where the treating clinician has determined that therapeutic intervention is necessary.

Exclusion criteria

  • Concurrent participation in any interventional clinical trial that, in the judgment of the investigator, could interfere with the data collection or outcome assessment of this observational study.

Trial design

1,500 participants in 1 patient group

Normal treatment
Description:
Treatment without intervention of catheter ablation or Implantable cardioverter defibrillator.
Treatment:
Device: Intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems